Translational Development Acquisition Corp. (TDACU) Free Cash Flow (2024 - 2026)

Translational Development Acquisition (TDACU) has 3 years of Free Cash Flow data on file, last reported at -$305157.0 in Q1 2026.

• Quarterly Free Cash Flow fell 31.78% year-over-year to -$305157.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$681970.0 (up 34.59% YoY) and the FY2025 annual result came in at -$608387.0, up 28.55% from the prior year.
• Free Cash Flow slipped to -$305157.0 in Q1 2026, from -$117363.0 in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$88105.0 in Q3 2025 to a low of -$810963.0 in Q4 2024.
• A 3-year average of -$287417.8 and a median of -$201459.5 in 2025 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2025 — Free Cash Flow jumped 85.53% — and 2026, when it slumped 31.78%.
• Tracing TDACU's Free Cash Flow over 3 years: stood at -$810963.0 in 2024, then jumped by 85.53% to -$117363.0 in 2025, then tumbled by 160.01% to -$305157.0 in 2026.
• The last three Free Cash Flow figures came in at -$305157.0 (Q1 2026), -$117363.0 (Q4 2025), and -$88105.0 (Q3 2025), per Business Quant data.